|
IMPACTT Newsletter | August 2020
|
|
Discover IMPACTT most recent breakthroughs as well as new tools for microbiome research and fresh news from our microbiome community. As a member of our microbiome research community, we will be thrilled to share News you find relevant for our microbiome community, just send us an email to [email protected] and we will get back to you.
|
|
|
|
|
Dr. Anita Kozyrskyj is a Professor at the Department of Pediatrics, University of Alberta. As an expert in epidemiological research using population-based birth cohort studies, Dr. Kozyrskyj leads SyMBIOTA, the Synergy in Microbiota Research funded by CIHR and develops the CHILD Cohort Study. At IMPACTT, Dr. Kozyrskyj supports researchers by helping with their cohort studies. Dr. Kozyrskyj recent breakthroughs on the impact of environmental factors in early-life microbiome and immune development were recently highlighted in Allergen and EurekaAlert! here and here . In a special interview, she talks about her journey, views and experiences during her career.
|
|
|
|
|
|
Scientific breakthroughs
|
- Vitamin D supplementation in pregnancy and early infancy in relation to gut microbiota composition and C. difficile colonization: implications for viral respiratory infections. Drall K. M., et al. Gut Microbes. 2020 August 11. Studying 1,157 mother-infant pairs of the CHILD Cohort. Drall, Dr. Kozyrskyj's team and colleagues unravel a possible link between vitamin D supplementation during early-life and protection against C. difficile infection.
- Tacrolimus impairs Kupffer cell capacity to control bacteremia: why transplant recipients are susceptible to infection. Deppermann C, et al. Hepatology, 2020 Aug 6. Using a define mouse model of acute methicillin-resistant Staphylococcus aureus (MRSA) bacteremia along with intravital microscopy, Deppermann C, et al. discovered why Tacrolimus, a drug used to prevent rejection in solid organ transplant recipients increases the susceptibility of transplant recipient to develop a bacterial infection
- Programing of an Intravascular Immune Firewall by the Gut Microbiota Protects against Pathogen Dissemination during Infection. B. McDonald, A. Z. Zucoloto et al. Cell Host & Microbe. 17 August 2020. Treating germ-free and gnotobiotic mice with D- Lactate, together with in vivo imaging, the authors unveiled that microbial D-lactate is a modulator of an intravascular immune firewall that protects against the spread of bacterial infections via the bloodstream.
|
|
New tools for microbiome studies
|
|
|
|
|
|
|
Upcoming virtual events
|
- Worlds of Microbiome Pregnancy, Birth and Infancy and Digestive and Metabolic Health are going virtual from 4 to 6 November 2020, more info here.
- The Microbiome Movement is organizing a series of conferences tailored to promote the translation of microbiome R&D into commercially viable products. Topic includes Human Nutrition, Pregnancy & Early-life, and more.
- The 4th International Conference on Microbiome, Probiotics & Gut Nutrition is going virtual from December 7 to 8, 2020.
|
|
|
|
A note from us: IMPACTT platforms are back-up at 100%
|
|
|
|
|
|
Thank you all for your interest and involvement in building a more connected and knowledgeable microbiome community!
|
|
|
|
|
|
|